Journal of Pediatric Nursing
Volume 23, Issue 5 , Pages 345-357 , October 2008

Attention Deficit/Hyperactivity Disorder: A Review and Update

  • Eileen Cormier, PhD, RN

      Affiliations

    • Corresponding Author InformationCorresponding author: Eileen Cormier, PhD, Florida State University College of Nursing, 421 Vivian M. Duxbury Hall, Tallahassee, FL 32306-4310.

References 

  1. Abikoff H, Hechtman L, Klein RG, Weiss G, Fleiss K, Etovitch J, et al. Symptomatic improvement in children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. Journal of the American Academy of Child and Adolescent Psychiatry. 2004;43:802–811
  2. American Academy of Child and Adolescent Psychiatry . Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. Journal of the Academy of Child and Adolescent Psychiatry. 1997;36(Suppl.):85–121
  3. American Academy of Child and Adolescent Psychiatry . Practice parameters for the use of stimulant medications in the treatment of children, adolescents, and adults. Journal of the Academy of Child and Adolescent Psychiatry. 2002;41(Suppl. 2):26–49
  4. American Academy of Pediatrics . Clinical practice guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics. 2000;105:1058–1070
  5. American Academy of Pediatrics . Clinical practice guideline. Treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:1033–1044
  6. American Psychiatric Association . Diagnostic and statistical manual for mental disorders. 2nd ed.. Washington, DC: Author; 1967;
  7. American Psychiatric Association . Diagnostic and statistical manual for mental disorders. 3rd ed.. Washington, DC: Author; 1980;
  8. American Psychiatric Association . Diagnostic and statistical manual for mental disorders. 3rd ed. Rev.. Washington, DC: Author; 1987;
  9. American Psychiatric Association . Diagnostic and statistical manual for mental disorders. 4th ed.. Washington, DC: Author; 1994;
  10. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed., Text rev.. Washington, DC: Author; 2000;
  11. Argold A, Erkanli A, Egger HL, Costello EJ. Stimulant treatment for children: A community perspective. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39:975–994
  12. Arnold LE, Abikoff HB, Cantwell DP, Connors CK, Elliot GE, Greenhill LL. NIMH collaborative multimodal treatment study of children with ADHD (MTA): Design, methodology, and protocol evolution. Journal of Attention Disorders. 1997;2:141–158
  13. Banaschewski T, Neale B, Rotthenberger A, Roessner V. Comorbidity of tic disorders & ADHD: Conceptual and methodological considerations. European Child and Adolescent Psychiatry. 2007;1(Suppl. 1):5–14
  14. Barkley RA. Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment. 3rd ed.. New York: Guilford Press; 2006;
  15. Bateman B, Warner JO, Hutchison E, Dean T, Rowlandson P, Gant C, et al. The effects of a double blind, placebo controlled, artificial food colorings and benzoate preservative challenge on hyperactivity in a general population sample of preschool children. Archives of Disease in Childhood. 2004;89:506–511
  16. Biederman J, Faraone SV, Taylor A, Sienna M, Williamson S, Fine C. Diagnostic continuity between child and adolescent ADHD: Findings from a longitudinal clinical sample. Journal of the American Academy of Child and Adolescent Psychiatry. 1998;37:305–313
  17. Biederman J, Mick E, Faraone SV. Age dependent decline in symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. American Journal of Psychiatry. 2000;157:816–818
  18. Bradley C. The behavior of children receiving benzedrine. American Journal of Psychiatry. 1937;94:577–588
  19. Brassett-Harknett A, Butler N. Attention-deficit/hyperactivity disorder: An overview of the etiology and a review of the literature relating to the correlates and lifecourse outcomes for men and women. Clinical Psychology Review. 2007;27:188–210
  20. Breismeister JM, Schaefer CE. Handbook of parent training: Parents as co-therapists for children's behavior problems. New York: John Wiley & Sons, Inc.; 1998;
  21. Brown RT, Antonuccio DO, DuPaul GJ, Fristad MA, King CA, Leslie LK, et al. Attention deficit hyperactivity disorder. In:  Brown RT, et al. editor. Childhood mental health disorders: Evidence base and contextual factors for psychosocial, psychopharmacological, and combined interventions. Washington, DC: American Psychological Association; 2008;p. 15–32
  22. Brown RT, Freeman WS, Perrin JM, Stein MT, Amler RW, Feldman HM, et al. Prevalence and assessment of attention-deficit/hyperactivity disorder in primary care settings. Pediatrics. 2001;107:e43
  23. Bussing R, Gary F, Mills TL, Garvan CW. Cultural variations in parental health beliefs, knowledge, and information sources related to attention-deficit/hyperactivity disorder. Journal of Family Issues. 2007;28:291–318
  24. Bussing R, Lebninger F, Eyberg S. Difficult child temperament and attention-deficit/hyperactivity disorder in preschool children. Infants and Young Children. 2006;19:123–131
  25. Chacko A, Pelham WE, Gnagy EM, Greiner A, Vallano G, Bukstein O, et al. Stimulant medication effects in a natural setting among young children with attention-deficit/hyperactivity disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 2005;4:249–257
  26. Chronis AM, Chacko A, Fabiano GA, Wymbs BT, Pelham WE. Enhancements to the behavioral parent training paradigm for families of children with ADHD: Review and future directions. Clinical Child and Family Psychology Review. 2004;7:1–27
  27. Chronis AM, Jones HA, Raggi VL. Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. Clinical Psychology Review. 2006;26:486–502
  28. Clements SD. Minimal brain dysfunction in children: Terminology and identification. Washington, DC: U.S. Department of Health, Education, and Welfare; 1966;
  29. Cohen RA. The neuropsychology of attention. New York: Plenum; 1993;
  30. Connors K. Connors Rating Scales-Revised: Technical manual. North Tonawanda, NY: Multi-Health Systems; 1997;
  31. Connors CK, Epstein J, Marsh J. Multi-modal treatment of ADHD (MTA): An alternative outcome analysis. Journal of the Academy of Child and Adolescent Psychiatry. 2001;40:159–167
  32. Connors K, Marsh JS, Frances A, Wells KC, Ross R. Treatment of attention deficit/hyperactivity disorder: Expert consensus guidelines. Journal of Attention Disorders. 2001;4:7–128
  33. Daly BP, Creed T, Xanthopoulos M, Brown RT. Psychosocial treatments for children with attention deficit/hyperactivity disorder. Neuropsychiatry Review. 2007;17:73–89
  34. Danforth JS, Harvey E, Ulaszek WR, McKee TE. The outcome of group parent training for families of children with attention-deficit hyperactivity disorder and defiant/aggressive behavior. Journal of Behavior Therapy and Experimental Psychiatry. 2006;37:188–205
  35. DeMarle, D.J., Denk, L., & Ernsthausen, C.S. (2003). Working with the family of a child with attention deficit hyperactivity disorder. Pediatric Nursing, 29, 302–304, 307–308, 330.
  36. Dengate S, Ruben A. Controlled trial of cumulative behavioral effects of a common bread preservative. Journal of Pediatric Child Health. 2002;38:373–376
  37. Dewey D, Kaplan BJ, Crawford SG, Wilson N. Developmental coordination disorder: Associated problems in attention, learning, and psychosocial adjustment. Human Movement Science. 2002;21:905–918
  38. Egger HL, Kondo D, Angold A. The epidemiology and diagnostic issues in preschool attention-deficit/hyperactivity disorder: A review. Infants and Young Children. 2006;19:109–122
  39. Ehlers S, Gillberg C. The epidemiology of Asperger syndrome. A total population study. Journal of Child Psychology and Psychiatry. 1993;34:1327–1350
  40. Faraone SV. Advances in the genetics and neurobiology of attention deficit hyperactivity disorder. Biological Psychiatry. 2006;60:1025–1027
  41. Faraone S, Biederman J, Monuteaux MC. Further evidence for the diagnostic continuity between child and adolescent ADHD. Journal of Attentional Disorders. 2002;6:5–13
  42. Faraone S, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: Is it an American condition?. World Psychiatry. 2003;2:104–113
  43. Gillberg C, Gillberg IC, Rasmussen P, Bjorn K, Soderstrom H, Rastam M, et al. Co-existing disorders in ADHD––Implications for diagnosis and intervention. European Child and Adolescent Psychiatry. 2004;13(Suppl. 1):80–92
  44. Goldman LS, Genel M, Bezman R, Slanetz PJ. Diagnosis and treatment of attention-deficit/hyperactivty disorder in children and adolescents. Journal of the American Medical Association. 1998;279:1100–1107
  45. Goldstein S, Goldstein M. Managing attention deficit hyperactivity disorders in children: A guide for practitioners. 2nd ed.. New York: Wiley; 1998;
  46. Gomez R, Condon M. Central auditory processing ability in children with ADHD with and without learning disabilities. Journal of Learning Disabilities. 1999;32:150–158
  47. Goodman DW. The consequences of attention-deficit/hyperactivity in adults. Journal of Psychiatric Practice. 2007;13:318–327
  48. Green M, Wong M, Atkins D, Feinlieb M. Diagnosis of attention deficit/hyperactivity disorder. (Technical Rev. No. 3 AHCPR Publication No. 99-0050). Rockville, MD: Agency for Health Care Policy and Research; 1999;
  49. Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, et al. Practice parameters for the use of stimulant medication in the treatment of children, adolescents, and adults. Journal of the American Academy of Child and Adolescent Psychiatry. 2002;41(Suppl. 2):26–49
  50. Hillemeier MM, Foster EM, Heinrichs B, Brigitt H. Racial differences in parental reports of attention-deficit/hyperactivity disorder behaviors. Journal of Developmental and Behavioral Pediatrics. 2007;28:353–361
  51. Hinshaw SP, Owens EB, Wells KC, Kraemer HC, Abikoff L, Arnold E, et al. Family Processes and treatment outcomes in the MTA: Negative/ineffective parenting practices in relation to multimodal treatment. Journal of Abnormal Psychology. 2000;28:555–568
  52. Jahad AR, Boyle M, Cunningham C, et al. Treatment of attention-deficit/hyperactivity disorder. (Evidence report/Technology assessment no. 11). Rockville, MD: Agency for Healthcare Research and Quality; 1999;
  53. Jensen PS, Martin D, Cantwell DP. Comorbidity in ADHD: Implications for research, practice and DSM-IV. Journal of the Academy of Child and Adolescent Psychiatry. 1997;36:1065–1079
  54. Jensen SP, Hinshaw SP, Swanson JM, Greenhill LL, Connors CK, Arnold LE, et al. Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers. Journal of Developmental and Behavioral Pediatrics. 2001;22:60–73
  55. Kadesjo B, Gillberg C. The comorbidity of ADHD in the general population of Swedish school-age children. Journal of Child Psychology and Psychiatry. 2001;42:487–492
  56. Ke X, Zou I, Hong S, Hang J, Zu-Hong LT, Cathay P. Attention deficit and hyperactivity symptoms in school children with Asperger syndrome. Chinese Mental Health Journal. 2007;21:86–89
  57. Kendall J, Hatton D. Racism as a source of health disparity in families of children with attention deficit hyperactivity disorder. Advances in Nursing Science. 2002;25:22–39
  58. Kent L, Craddock N. Is there a relationship between attention deficit hyperactivity disorder and bipolar disorder?. Journal of Affective Disorders. 2003;73:211–221
  59. Lahey BB, Pelham W, Stein MA, Loney J, Trapini C, Nugent K, et al. Validity of DSM-IV attention-deficit/hyperactivity disorder for younger children. Journal of the Academy of Child and Adolescent Psychiatry. 1998;37:695–702
  60. Lalonde J, Turgay A, Hudson JI. Attention-deficit hyperactivity subtypes and comorbid disruptive behavior disorders in child and adolescent mental health centers. Canadian Journal of Psychiatry. 1998;43:623–628
  61. Lavigne C, Cicchetti R, Gibbon HJ, Binns HJ, Larsen L, DeVito C. Oppositional defiant disorder with onset of preschool years: Longitudinal stability and pathways to other disorders. Journal of the Academy of Child and Adolescent Psychiatry. 2001;40:1393–1400
  62. Levin H, Hanten G, Max J, Li X, Swank P, Ewing-Cobbs L, et al. Symptoms of attention-deficit/hyperactivity disorder following traumatic brain injury. Journal of Developmental and Behavioral Pediatrics. 2007;28:108–118
  63. Liu YH, Leslie LK. Diagnosing ADHD: Putting AAP guidelines to the test and into practice. Contemporary Pediatrics. 2003;20:51–73
  64. Loeber R, Burke JD, Lahey BB, Winters A, Zera M. Oppositional defiant disorder and conduct disorder: A review of the past 10 years, Part I. Journal of the American Academy of Child and Adolescent Psychiatry. 2000;39:1468–1484
  65. Lopez FA. ADHD: New pharmacological treatments on the horizon. Developmental and Behavioral Pediatrics. 2006;27:410–416
  66. Luca P, Laurin N, Misener VL, Wigg KG, Anderson B, Cate-Carter T, et al. Association of the dopamine receptor D1 gene, DDD1, with inattention symptoms in families selected for reading problems. Molecular Psychiatry. 2007;12:776–785
  67. Magyary D, Brandt P. A decision tree and clinical paths for the assessment and management of children with ADHD. Issues in Mental Health Nursing. 2002;23:553–566
  68. Maria A, Pedron M, Cornoldi C. Expressive writing difficulties in children described as exhibiting ADHD symptoms. Journal of Learning Disabilities. 2007;40:244–255
  69. McCabe SE, Teter CJ, Boyd CJ. The use, misuse, and diversion of prescription stimulants among middle and high school students. Substance Use and Misuse. 2004;39:1095–1116
  70. Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C, et al. Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized placebo-controlled, dose-response study. American Journal of Psychiatry. 2002;159:1896–1901
  71. Morgan AE, Hynd GW, Riccio CA, Hall J. Validity of DSM-IV ADHD predominantly inattentive and combined types: Relationship to previous DSM diagnoses/subtype differences. Journal of the Academy of Child and Adolescent Psychiatry. 1996;35:325–333
  72. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry. 1999;56:1073–1086
  73. MTA Cooperative Group. National Institute of Mental Health multimodal treatment study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit hyperactivity disorder. Pediatrics. 2004;113:754–761
  74. Nissen SE. ADHD drugs and cardiovascular risk. New England Journal of Medicine. 2006;354:1445–1448
  75. Pastor PN, Reuben CA. Racial and ethnic differences in ADHD and LD in young school-age children: Parental reports in the national interview survey. Public Health Reports. 2005;120:383–392
  76. Pelham WE, Wheeler T, Chronis A. Empirically supported psychosocial treatments for attention deficit hyperactivity disorder. Journal of Clinical Child Psychology. 1998;27:190–205
  77. Pitcher TM, Piek JP, Hay DA. Fine and gross motor ability in males with ADHD. Developmental Medicine and Child Neurology. 2003;45:525–535
  78. Plizka SR. Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America. 2000;9:525–540
  79. Raggio DJ. Visuomotor perception in children with attention deficit hyperactivity-combined type. Perceptual and Motor Skills. 1999;88:448–450
  80. Rains A, Scahill L. Psychopharmacology notes: Nonstimulant medications for the treatment of ADHD. Journal of Child and Adolescent Psychiatric Nursing. 2006;19:44–47
  81. Resnick RJ. The hidden disorder: A clinician's guide to attention deficit hyperactivity disorder in adults. Washington, DC: American Psychological Association; 2000;
  82. Richters JE, Arnold LE, Jensen PS, Abikoff H, Connors CK, Greenhill LL, et al. NIMH collaborative multisite, multimodal treatment study of children with ADHD: Background and rationale. Journal of the American Academy of Child and Adolescent Psychiatry. 1995;34:987–1000
  83. Robison LM, Sclar DA, Skaer TL, Galin RS. National trends in the prevalence and the prescribing of methylphenidate among school-age children: 1990–1995. Clinical Pediatrics. 1999;38:209–217
  84. Roessner V, Robatzek M, Knapp G, Banaschewski T, Rothenberger A. First onset tics in patients with attention-deficit/hyperactivity disorder: Impact of stimulants. Developmental Medicine and Child Neurology. 2006;48:616–621
  85. Rojas NL, Chan E. Old and new controversies in the alternative treatment of attention-deficit hyperactivity disorder. Mental Retardation and Developmental Disabilities Research Reviews. 2005;11:116–130
  86. Root RW, Resnick RJ. An update on the diagnosis and treatment of attention-deficit/hyperactivity disorder in children. Professional Psychology: Research and Practice. 2003;34:34–41
  87. Rushton JL, Fant KE, Clark SJ. Use of practice guidelines in the primary care of children with attention-deficit/hyperactivity disorder. Pediatrics. 2004;114:23–28
  88. Schab DW, Trinh NT. Do artificial food colors promote hyperactivity in children with hyperactive syndromes? A meta-analysis of double-blind placebo-controlled trials. Developmental and Behavioral Pediatrics. 2004;25:423–434
  89. Schmidt M, Mocks P, Lay B, Eisert H, Fojkar R, Fritz-Sigmund D, et al. Does oligoantigenic diet influence hyperactive/conduct-disordered children—A controlled trial. European Child and Adolescent Psychiatry. 1997;6:88–95
  90. Schnoll R, Burshteyn D, Cea-Aravena J. Nutrition in the treatment of attention-deficit hyperactivity disorder: A neglected but important aspect. Applied Psychobiology and Biofeedback. 2003;28:63–72
  91. Sciutto MJ, Eisenberg M. Evaluating the evidence for and against the overdiagnosis of ADHD. Journal of Attention Disorders. 2007;11:106–113
  92. Spencer TJ, Biederman J, Coffey B, Geller D, Crawford M, Bearman SK, et al. A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Archives of General Psychiatry. 2002;59:649–656
  93. Spencer TJ, Biederman J, Mick E. Attention-deficit/hyperactivity disorder: Diagnosis, lifespan, comorbidities, and neurobiology. Ambulatory Pediatrics. 2007;7:73–81
  94. Sobanski E. Psychiatric comorbidity in adults with attention/deficit hyperactivity disorder (ADHD). European Archives in Clinical Neuroscience. 2006;256(Suppl. l):26–31
  95. Steinhausen HC, Novik TS, Baldursson G, Curatolo P, Lorenzo M, Pereira RR, et al. Co-existing psychiatric problems in ADHD in the ADORE cohort. European Child and Adolescent Psychiatry. 2006;15(Suppl.):25–29
  96. Stevens S. Attention deficit/hyperactivity disorder: Working the system for better diagnosis and treatment. Journal of Pediatric Nursing. 2005;20:47–51
  97. Swanson JM, Kraemer HC, Hinshaw SP. Clinical relevance of primary findings of the MTA: Success rates based on severity of ADHD and ODD symptoms at the end of treatment. Journal of the Academy of Child and Adolescent Psychiatry. 2001;40:168–179
  98. Swanson JM, Lerner M, Marsh J, Gresham F. Assessment and intervention for ADHD: Lessons from the MTA study. Pediatric Clinics of North America. 1999;46:993–1009
  99. Timimi S. The politics of attention deficit hyperactivity disorder (ADHD). In:  Timimi S,  Maitra B editor. Critical voices in child and adolescent mental health. London, England: Free Association Books; 2006;p. 163–191
  100. Tripp G, Schaughency EA, Clarke B. Parent and teacher rating scales in the evaluation of attention-deficit hyperactivity disorder: Contribution to diagnosis and differential diagnosis in clinically-referred children. Journal of Developmental and Behavioral Pediatrics. 2006;27:209–218
  101. Trott GE. Attention-deficit/hyperactivity disorder (ADHD) in the course of life. European Archives of Psychiatry and Clinical Neuroscience. 2006;256(Suppl. 1):21–25
  102. Valente SM. Treating attention deficit hyperactivity disorder. The Nurse Practitioner. 2001;26:14–26
  103. Valera EM, Siedman LJ. Neurobiology of attention-deficit/hyperactivity disorder in preschoolers. Infants and Young Children. 2006;19:94–108
  104. Waldman ID, Gizer IR. The genetics of attention deficit hyperactivity disorder. Clinical Psychology Review. 2006;26:396–432
  105. Weiss M, Murray C. Assessment and management of attention-deficit hyperactivity disorder in adults. Canadian Medical Association Journal. 2003;168:715–722
  106. Wells KC, Hinshaw SP, Pfiffner L, Owens EB, Abikoff HB, Elliott GR, et al. Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit hyperactivity disorder. Journal of Consulting and Clinical Psychology. 2006;74:649–657
  107. Wender PH. Attention-deficit hyperactivity disorder in adults. New York: Oxford Press; 1995;
  108. Wilens TE, Biederman J, Brown S, Monuteaux M, Prince J, Spenser TJ. Patterns of psychopathology and dysfunction in clinically referred preschoolers. Journal of Developmental and Behavioral Pediatrics. 2002;23:531–537
  109. Wilens TE, Faraone S, Biederman J, Gunawardene S. Does stimulant therapy of attention/deficit hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics. 2003;111:179–185
  110. Wilens TE, Gignac M, Swezey A, Monuteaux MC, Biederman J. Characteristics of adolescents and young adults with ADHD who divert or misuse their prescribed medications. Journal of the American Academy of Child and Adolescent Psychiatry. 2006;45:408–414
  111. Wilens TE, Prince JB, Spenser TJ, Biederman J. Stimulants and sudden death: What is a physician to do?. Pediatrics. 2006;118:1215–1219
  112. Wolraich ML. An update on the diagnosis and treatment of attention-deficit/hyperactivity disorder in children. Professional Psychology Research and Practice. 2003;34:34–41
  113. Wolraich ML. Attention-deficit hyperactivity disorder: Can it be recognized and treated in children younger than 5 years?. Infants and Young Children. 2006;19:86–93
  114. Wolraich ML, Lambert EW, Bickman L, Simmons T, Doffing M, Worley K. Assessing the impact of parent and teacher agreement on diagnosing attention-deficit hyperactivity disorder. Journal of Developmental and Behavioral Pediatrics. 2004;25:41–47
  115. Wood JG, Crager J, Delap C, Heiskell K. Beyond methylphenidate: Nonstimulant medication for youth with ADHD. Journal of Attention Disorders. 2007;11:341–350
  116. Zito JM, Safer DJ, dosReis S, Magder L, Gardner JF, Zarin DA. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Archives in Pediatric Adolescent Medicine. 1999;153:1257–1263

PII: S0882-5963(08)00005-5

doi: 10.1016/j.pedn.2008.01.003

Journal of Pediatric Nursing
Volume 23, Issue 5 , Pages 345-357 , October 2008

Article Tools